Tabrizi, Sarah J.
UK Dementia Research Institute · UCL Queen Square Institute of Neurology · University College London
24 papers on CoChatORCID 0000-0003-2716-2045
Most cited papers
- Verified
Huntington disease
Bates, G. P., Dorsey, R., Gusella, J. F., Hayden, M. R., Kay, C., Leavitt, B. R., Nance, M., Ross, C. A., Scahill, R. I., Wetzel, R., et al. (2015) · Nature Reviews Disease Primers
Genetic Neurodegenerative DiseasesHereditary Neurological Disorders
Cited by 1,641
- Verified
Huntington disease: natural history, biomarkers and prospects for therapeutics
Ross, C. A., Aylward, E. H., Wild, E. J., Langbehn, D. R., Long, J. D., Warner, J. H., Scahill, R. I., Leavitt, B. R., Stout, J. C., Paulsen, J. S., et al. (2014) · Nature Reviews Neurology
Genetic Neurodegenerative DiseasesDeep Brain Stimulation and Movement Disorders
Cited by 1,016
- Verified
Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data
Tabrizi, S. J., Langbehn, D. R., Leavitt, B. R., Roos, R. A., Durr, A., Craufurd, D., Kennard, C., Hicks, S. L., Fox, N. C., Scahill, R. I., et al. (2009) · The Lancet Neurology
Genetic Neurodegenerative DiseasesDeep Brain Stimulation and Movement Disorders
Cited by 984
- Verified
Targeting Huntingtin Expression in Patients with Huntington’s Disease
Tabrizi, S. J., Leavitt, B. R., Landwehrmeyer, G. B., Wild, E. J., Saft, C., Barker, R. A., Blair, N. F., Craufurd, D., Priller, J., Rickards, H., et al. (2019) · New England Journal of Medicine
Genetic Neurodegenerative DiseasesLysosomal Storage Disorders Research
Cited by 708
- Verified
PINK1-associated Parkinson's disease is caused by neuronal vulnerability to calcium-induced cell death
Gandhi, S., Wood-Kaczmar, A., Yao, Z., Plun-Favreau, H., Deas, E., Klupsch, K., Downward, J., Latchman, D. S., Tabrizi, S. J., Wood, N. W., et al. (2009) · Molecular Cell
Parkinson's Disease Mechanisms and TreatmentsMitochondrial Function and Pathology
Cited by 682
- Verified
Microglial activation in presymptomatic Huntington's disease gene carriers
Tai, Y. F., Pavese, N., Gerhard, A., Tabrizi, S. J., Barker, R. A., Brooks, D. J., & Piccini, P. (2007) · Brain
Genetic Neurodegenerative DiseasesNeuroinflammation and Neurodegeneration Mechanisms
Cited by 440
- Verified
Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysis
Byrne, L. M., Rodrigues, F. B., Blennow, K., Durr, A., Leavitt, B. R., Roos, R. A. C., Scahill, R. I., Tabrizi, S. J., Zetterberg, H., Langbehn, D., et al. (2017) · The Lancet Neurology
Genetic Neurodegenerative DiseasesHereditary Neurological Disorders
Cited by 364
- Verified
Large C9orf72 Hexanucleotide Repeat Expansions Are Seen in Multiple Neurodegenerative Syndromes and Are More Frequent Than Expected in the UK Population
Beck, J., Poulter, M., Hensman, D., Rohrer, J. D., Mahoney, C. J., Adamson, G., Campbell, T., Uphill, J., Borg, A., Fratta, P., et al. (2013) · The American Journal of Human Genetics
Amyotrophic Lateral Sclerosis ResearchGenetic Neurodegenerative Diseases
Cited by 345
- Verified
PINK1 is necessary for long term survival and mitochondrial function in human dopaminergic neurons
Wood-Kaczmar, A., Gandhi, S., Yao, Z., Abramov, A. S. Y., Miljan, E. A., Keen, G., Stanyer, L., Hargreaves, I., Klupsch, K., Deas, E., et al. (2008) · PLoS ONE
Parkinson's Disease Mechanisms and TreatmentsNuclear Receptors and Signaling
Cited by 316
- Verified
DNA repair pathways underlie a common genetic mechanism modulating onset in polyglutamine diseases
Bettencourt, C., Hensman‐Moss, D., Flower, M., Wiethoff, S., Brice, A., Goizet, C., Stevanin, G., Koutsis, G., Karadima, G., Panas, M., et al. (2016) · Annals of Neurology
Genetic Neurodegenerative DiseasesGenetic factors in colorectal cancer
Cited by 227
- Verified
Microglial activation in regions related to cognitive function predicts disease onset in Huntington's disease: a multimodal imaging study
Politis, M., Pavese, N., Tai, Y. F., Kiferle, L., Mason, S. L., Brooks, D. J., Tabrizi, S. J., Barker, R. A., & Piccini, P. (2011) · Human Brain Mapping
Genetic Neurodegenerative DiseasesNeurological diseases and metabolism
Cited by 212
- Verified
C9orf72 expansions are the most common genetic cause of Huntington disease phenocopies
Hensman Moss, D. J., Poulter, M., Beck, J., Hehir, J., Polke, J. M., Campbell, T., Adamson, G., Mudanohwo, E., McColgan, P., Haworth, A., et al. (2014) · Neurology
Genetic Neurodegenerative DiseasesAmyotrophic Lateral Sclerosis Research
Cited by 203
- Verified
KEAP1-modifying small molecule reveals muted NRF2 signaling responses in neural stem cells from Huntington's disease patients
Quinti, L., Dayalan Naidu, S., Träger, U., Chen, X., Kegel-Gleason, K., Llères, D., Connolly, C., Chopra, V., Low, C., Moniot, S., et al. (2017) · Proceedings of the National Academy of Sciences
Genomics, phytochemicals, and oxidative stressGenetic Neurodegenerative Diseases
Cited by 140
- Verified
Brain-Derived Neurotrophic Factor in Patients with Huntington's Disease
Zuccato, C., Marullo, M., Vitali, B., Tarditi, A., Mariotti, C., Valenza, M., Lahiri, N., Wild, E. J., Sassone, J., Ciammola, A., et al. (2011) · PLoS ONE
Genetic Neurodegenerative DiseasesNerve injury and regeneration
Cited by 138
- Verified
Progressive alterations in the hypothalamic-pituitary-adrenal axis in the R6/2 transgenic mouse model of Huntington's disease
Björkqvist, M., Petersén, Å., Bacos, K., Isaacs, J., Norlén, P., Gil, J., Popovic, N., Sundler, F., Bates, G. P., Tabrizi, S. J., et al. (2006) · Human Molecular Genetics
Genetic Neurodegenerative DiseasesStress Responses and Cortisol
Cited by 138
- Verified
Huntington’s disease: Clinical presentation and treatment
Novak, M. J. U., & Tabrizi, S. J. (2011) · International Review of Neurobiology
Genetic Neurodegenerative DiseasesDeep Brain Stimulation and Movement Disorders
Cited by 137
- Verified
A SNP in the HTT promoter alters NF-κB binding and is a bidirectional genetic modifier of Huntington disease
REGISTRY Investigators of the European Huntington's Disease Network, Bečanović, K., Nørremølle, A., Neal, S. J., Kay, C., Collins, J. A., Arenillas, D., Lilja, T., Gaudenzi, G., Manoharan, S., et al. (2015) · Nature Neuroscience
Genetic Neurodegenerative DiseasesLysosomal Storage Disorders Research
Cited by 135
- Verified
Mutant huntingtin causes defective actin remodeling during stress: defining a new role for transglutaminase 2 in neurodegenerative disease
Munsie, L., Caron, N., Atwal, R. S., Marsden, I., Wild, E. J., Bamburg, J. R., Tabrizi, S. J., & Truant, R. (2011) · Human Molecular Genetics
Genetic Neurodegenerative DiseasesPrion Diseases and Protein Misfolding
Cited by 133
- Verified
Huntington disease
Ghosh, R., & Tabrizi, S. J. (2018) · Handbook of Clinical Neurology
Genetic Neurodegenerative DiseasesNeurological diseases and metabolism
Cited by 122
- Verified
Antisense oligonucleotides for neurodegeneration
Leavitt, B. R., & Tabrizi, S. J. (2020) · Science
Amyotrophic Lateral Sclerosis ResearchAlzheimer's disease research and treatments
Cited by 96
- Verified
In vivo characterization of white matter pathology in premanifest huntington's disease
Zhang, J., Gregory, S., Scahill, R. I., Durr, A., Thomas, D. L., Lehericy, S., Rees, G., Tabrizi, S. J., Zhang, H., & the TrackOn‐HD investigators (2018) · Annals of Neurology
Advanced Neuroimaging Techniques and ApplicationsGenetic Neurodegenerative Diseases
Cited by 80
- Verified
Cerebrospinal fluid inflammatory biomarkers reflect clinical severity in Huntington's disease
Rodrigues, F. B., Byrne, L. M., McColgan, P., Robertson, N., Tabrizi, S. J., Zetterberg, H., & Wild, E. J. (2016) · PLOS ONE
Genetic Neurodegenerative DiseasesNeuroinflammation and Neurodegeneration Mechanisms
Cited by 79
- Verified
Bone Marrow Transplantation Confers Modest Benefits in Mouse Models of Huntington's Disease
Kwan, W., Magnusson, A., Chou, A., Adame, A., Carson, M. J., Kohsaka, S., Masliah, E., Möller, T., Ransohoff, R., Tabrizi, S. J., et al. (2012) · The Journal of Neuroscience
Genetic Neurodegenerative DiseasesNeuroinflammation and Neurodegeneration Mechanisms
Cited by 75
- Verified
Effects of IONIS-HTTRx in Patients with Early Huntington’s Disease, Results of the First HTT-Lowering Drug Trial (CT.002)
Tabrizi, S., Leavitt, B., Kordasiewicz, H., Czech, C., Swayze, E., Norris, D. A., Baumann, T., Gerlach, I., Schobel, S., Smith, A., et al. (2018) · Neurology
Genetic Neurodegenerative DiseasesAmyotrophic Lateral Sclerosis Research
Cited by 26
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free